BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the Company's management will participate in the following investor conferences during the month of September: Morgan Stanley 22nd Annual Global Healthcare Conference Format: Fireside Chat Date: Friday, September 6, 2024 Time: 1:50 PM ET Webcast Link: click here H.C. Wainwright 26th Annual Global Investment Conference For ...